All-Trans Retinoic Acid-Induced Differentiation Factor (ATRAID) Peptide
ATRAID
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN974211
$160.46
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 11 to 17 Business Days
Quick Overview for All-Trans Retinoic Acid-Induced Differentiation Factor (ATRAID) Peptide (ABIN974211)
Target
ATRAID
(All-Trans Retinoic Acid-Induced Differentiation Factor (ATRAID))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-C2orf28 antibody (Catalog #: ARP30550_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ATRAID (All-Trans Retinoic Acid-Induced Differentiation Factor (ATRAID))
-
Background
-
The exact function of C2orf28 remains unknown.This gene is thought to be involved in apoptosis, and may also be involved in hematopoietic development and differentiation. Two alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: APR--3, APR-3, APR3, HSPC013, PRO240, p18, C2orf28
Protein Interaction Partner: LPP
Protein Size: 171 -
Molecular Weight
- 18 kDa
-
Gene ID
- 51374
-
NCBI Accession
- NM_016085, NP_057169
-
UniProt
- Q6UW56
Target
-
You are here:
